Puma Biotech gains on upbeat Q4 revenue, net profit

Puma Biotechnology

04/03/2022 11:09

** Shares of drugmaker  PBYI.O  jump 11.2% to $2.59
premarket
    ** Late on Thursday, PBYI reported Q4 revenue of $55.4 mln,
beating Refinitiv IBES estimates of $47.2 mln  urn:newsml:reuters.com:*:nBw2QwkzNa
    ** Co reports net income of $4.2 mln in the qtr vs net loss
of $15 mln a year ago on lower expense
    ** Results supported by strong demand for co's breast cancer
drug, Nerlynx
    ** Stock down 23.4% YTD, as of last close

 (Reporting by Amruta Khandekar in Bengaluru)
 ((Amruta.Khandekar@thomsonreuters.com;))